参考文献
关键文献
Soutar R, McSporran W, Tomlinson T, et al. Guideline on the investigation and management of acute transfusion reactions. Br J Haematol. 2023 Jun;201(5):832-44.全文 摘要
Panch SR, Montemayor-Garcia C, Klein HG. Hemolytic transfusion reactions. N Engl J Med. 2019 Jul 11;381(2):150-62. 摘要
Laureano M, Khandelwal A, Yan M. Canadian Blood Services. Clinical guide to transfusion: transfusion reactions (chapter 10). Oct 2022 [internet publication].全文
American Red Cross. A compendium of transfusion practice guidelines: fourth edition. 2021 [internet publication].全文
参考文献
1. Soutar R, McSporran W, Tomlinson T, et al. Guideline on the investigation and management of acute transfusion reactions. Br J Haematol. 2023 Jun;201(5):832-44.全文 摘要
2. AABB. Circular of information for the use of human blood and blood components. Dec 2021 [internet publication].全文
3. Panch SR, Montemayor-Garcia C, Klein HG. Hemolytic transfusion reactions. N Engl J Med. 2019 Jul 11;381(2):150-62. 摘要
4. Laureano M, Khandelwal A, Yan M. Canadian Blood Services. Clinical guide to transfusion: transfusion reactions (chapter 10). Oct 2022 [internet publication].全文
5. American Red Cross. A compendium of transfusion practice guidelines: fourth edition. 2021 [internet publication].全文
6. Semple JW, Rebetz J, Kapur R. Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood. 2019 Apr 25;133(17):1840-53.全文 摘要
7. Vlaar APJ, Toy P, Fung M, et al. A consensus redefinition of transfusion-related acute lung injury. Transfusion. 2019 Jul;59(7):2465-76.全文 摘要
8. Foukaneli T, Kerr P, Bolton-Maggs PHB, et al. Guidelines on the use of irradiated blood components. Br J Haematol. 2020 Dec;191(5):704-24.全文 摘要
9. Linden JV, Wagner K, Voytovich AE, et al. Transfusion errors in New York state: an analysis of 10 years' experience. Transfusion. 2000 Oct;40(10):1207-13. 摘要
10. Spiess BD. Risks of transfusion: outcome focus. Transfusion. 2004 Dec;44(12 Suppl):4S-14S. 摘要
11. Karim F, Moiz B, Shamsuddin N, et al. Root cause analysis of non-infectious transfusion complications and the lessons learnt. Transfus Apher Sci. 2014 Feb;50(1):111-7. 摘要
12. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion. 1990 Sep;30(7):583-90. 摘要
13. Yazer MH, Podlosky L, Clarke G, et al. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion. 2004 Jan;44(1):10-5. 摘要
14. Paglino JC, Pomper GJ, Fisch GS, et al. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion. 2004 Jan;44(1):16-24. 摘要
15. King KE, Shirey RS, Thoman SK, et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion. 2004 Jan;44(1):25-9. 摘要
16. Tobian AA, King KE, Ness PM. Transfusion premedications: a growing practice not based on evidence. Transfusion. 2007 Jun;47(6):1089-96. 摘要
17. Domen RE, Hoeltge GA. Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med. 2003 Mar;127(3):316-20.全文 摘要
18. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev. 2006 Oct;20(4):273-82. 摘要
19. Vamvakas EC, Pineda AA, Reisner R, et al. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion. 1995 Jan;35(1):26-32. 摘要
20. Mazzei CA, Popovsky MA, Kopko PM. Noninfectious complications of blood transfusion. In: Roback JD, Combs MR, Grossman BJ, et al., eds. Technical Manual, 16th Ed. Bethesda, MD: American Association of Blood Banks; 2008:715-49.
21. Hawkins J, Aster RH, Curtis BR. Post-transfusion purpura: current perspectives. J Blood Med. 2019;10:405-15.全文 摘要
22. Finlay HE, Cassorla L, Feiner J, et al. Designing and testing a computer-based screening system for transfusion-related acute lung injury. Am J Clin Pathol. 2005 Oct;124(4):601-9. 摘要
23. Rana R, Fernandez-Perez ER, Khan SA, et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion. 2006 Sep;46(9):1478-83. 摘要
24. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005 Mar 15;105(6):2266-73. 摘要
25. Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest. 2004 Jul;126(1):249-58. 摘要
26. Lilic D, Sewell WA. IgA deficiency: what we should-or should not-be doing. J Clin Pathol. 2001 May;54(5):337-8.全文 摘要
27. Heddle NM. Pathophysiology of febrile nonhemolytic transfusion reactions. Curr Opin Hematol. 1999 Nov;6(6):420-6. 摘要
28. Middelburg RA, van Stein D, Briët E, et al. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion. 2008 Oct;48(10):2167-76. 摘要
29. Dwyre DM, Holland PV. Transfusion-associated graft-versus-host disease. Vox Sang. 2008 Aug;95(2):85-93. 摘要
30. Carson JL, Stanworth SJ, Dennis JA, et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042.全文 摘要
31. Yomtovian RA, Palavecino EL, Dykstra AH, et al. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Transfusion. 2006 May;46(5):719-30. 摘要
32. Leiby DA, Kerr KL, Campos JM, et al. A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites. Transfusion. 1997 Mar;37(3):259-63. 摘要
33. Yamada C, Edelson M, Lee A, et al. Transfusion-associated hyperkalemia in pediatric population: prevalence, risk factors, survival, infusion rate, and RBC unit features. Transfusion. 2021 Apr;61(4):1093-101. 摘要
34. Au BK, Dutton WD, Zaydfudim V, et al. Hyperkalemia following massive transfusion in trauma. J Surg Res. 2009 Dec;157(2):284-9. 摘要
35. Raza S, Ali Baig M, Chang C, et al. A prospective study on red blood cell transfusion related hyperkalemia in critically ill patients. J Clin Med Res. 2015 Jun;7(6):417-21.全文 摘要
36. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005 Apr;33(4):721-6. 摘要
37. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis - an overview for clinicians. Crit Care. 2005 Apr;9(2):158-69.全文 摘要
38. PAK CY. Mannitol for transfusion reaction. Br Med J. 1963 May 4;1(5339):1236-7. 摘要
39. Slavc I, Urban C, Schwinger W, et al. ABO-incompatible bone marrow transplantation: prevention of hemolysis by alkaline hydration with mannitol diuresis in conjunction with red cell reduced buffy coat bone marrow. Wien Klin Wochenschr. 1992;104(4):93-6. 摘要
40. Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020 Apr;145(4):1082-123.全文 摘要
41. LoVerde D, Iweala OI, Eginli A, et al. Anaphylaxis. Chest. 2018 Feb;153(2):528-43. 摘要
42. Amoral DA. NEJM Journal Watch: Updated anaphylaxis guidelines. Apr 2020 [internet publication].
43. Mueller-Eckhardt C, Kiefel V. High-dose IgG for post-transfusion purpura--revisited. Blut. 1988 Oct;57(4):163-7. 摘要
44. Anderson D, Ali K, Blanchette V, et al. Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus Med Rev. 2007 Apr;21(2 suppl 1):S9-56. 摘要
45. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000 Aug;30(8):1144-50. 摘要
46. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009 Apr 9;113(15):3406-17.全文 摘要
47. Perrota PL, Snyder EL. Non-infectious complications of transfusion therapy. Blood Rev. 2001 Jun;15(6):69-83. 摘要
48. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol. 2005 Sep;95(3):217-26. 摘要
49. National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. 24 August 2020 [internet publication].全文
50. Geiger TL, Howard SC. Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev. 2007 Jan;21(1):1-12. 摘要
51. Blajchman MA. The clinical benefits of the leukoreduction of blood products. J Trauma. 2006 Jun;60(6 Suppl):S83-90. 摘要
52. Martí-Carvajal AJ, Solà I, González LE, et al. Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions. Cochrane Database Syst Rev. 2010 Jun 16;6:CD007539. 摘要
53. Australian & New Zealand Society of Blood Transfusion. Guidelines for prevention of transfusion-associated graft-versus-host disease (TA-GVHD). Sydney, Australia: Australian & New Zealand Society of Blood Transfusion Ltd; 2011.全文
54. Middelburg RA, van Stein D, Zupanska B, et al. Female donors and transfusion-related acute lung injury. Transfusion. 2010 Nov;50(11):2447-54. 摘要
55. Schmickl CN, Mastrobuoni S, Filippidis FT, et al. Male-predominant plasma transfusion strategy for preventing transfusion-related acute lung injury: a systematic review. Crit Care Med. 2015 Jan;43(1):205-25. 摘要
56. Müller MC, van Stein D, Binnekade JM, et al. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis. Transfusion. 2015 Jan;55(1):164-75. 摘要
内容使用需遵循免责声明